BAJAJ BROKING

Notification
No new Notification messages
One Mobikwik Systems IPO is Open!
Apply for the One Mobikwik Systems IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
shree ganesh remedies limited stock

Shree Ganesh Remedies Limited Share Price

744.15 20.35 (2.81%)
Dec 11 2024 03:30 PM Pharmaceuticals NSE: SGRL

Shree Ganesh Remedies Limited Share Price Update

As of the latest trading session, Shree Ganesh Remedies Limited share price is currently at 744.15, which is up by 20.35 from its previous closing. Today, the stock has fluctuated between 728.00 and 748.90. Over the past year, Shree Ganesh Remedies Limited has achieved a return of 21.19 %. In the last month alone, the return has been -4.64 %. Read More...

Shree Ganesh Remedies Limited Performance

Day Range

Low728.00 High748.90
744.15

52 Week Range

Low 557.95 High 950.05
744.15

Shree Ganesh Remedies Limited Share Price

540737

SGRL

img img img img
No Data Available

Open Price

748.90

Prev. Close

723.80

Volume (Shares)

4283.00

Total traded value

31.78

Upper Circuit

.00

Lower Circuit

.00

Note: The current prices & values are delayed, Login to your account for live updates.

Shree Ganesh Remedies Limited Fundamentals


(Standalone)

Market Cap (Cr) 956.02
PE Ratio (TTM) 34.01
Book Value / Share 103.72
Beta 0.58
ROE 26.87%
EPS (TTM) 21.88
Dividend Yield 0.07%
Net Profit Qtr (Cr) 6.42

Shree Ganesh Remedies Limited Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 32.33
Operating Expense 23.88
Net Profit 6.42
Net Profit Margin (%) 19.85
Earnings Per Share (EPS) 4.98
EBITDA 11.50
Effective Tax Rate (%) 25.78
Particulars JUN 2024 (Values in Cr)
Revenue 24.78
Operating Expense 18.99
Net Profit 4.65
Net Profit Margin (%) 18.76
Earnings Per Share (EPS) 3.62
EBITDA 8.67
Effective Tax Rate (%) 26.54
Particulars MAR 2024 (Values in Cr)
Revenue 37.33
Operating Expense 22.41
Net Profit 12.59
Net Profit Margin (%) 33.72
Earnings Per Share (EPS) 10.01
EBITDA 18.25
Effective Tax Rate (%) 22.52
Particulars DEC 2023 (Values in Cr)
Revenue 28.16
Operating Expense 21.94
Net Profit 4.43
Net Profit Margin (%) 15.73
Earnings Per Share (EPS) 3.52
EBITDA 9.23
Effective Tax Rate (%) 37.16
Particulars SEP 2023 (Values in Cr)
Revenue 33.42
Operating Expense 25.61
Net Profit 6.55
Net Profit Margin (%) 19.59
Earnings Per Share (EPS) 5.34
EBITDA 10.03
Effective Tax Rate (%) 23.80
Particulars MAR 2024 (Values in Cr)
Revenue 125.90
Operating Expense 90.78
Net Profit 28.12
Net Profit Margin (%) 22.33
Earnings Per Share (EPS) 22.35
EBITDA 44.88
Effective Tax Rate (%) 26.32
Particulars MAR 2023 (Values in Cr)
Revenue 91.36
Operating Expense 71.84
Net Profit 15.18
Net Profit Margin (%) 16.61
Earnings Per Share (EPS) 12.54
EBITDA 24.15
Effective Tax Rate (%) 24.95
Particulars MAR 2022 (Values in Cr)
Revenue 71.29
Operating Expense 56.86
Net Profit 13.40
Net Profit Margin (%) 18.79
Earnings Per Share (EPS) 11.16
EBITDA 21.50
Effective Tax Rate (%) 25.59
Particulars MAR 2021 (Values in Cr)
Revenue 49.08
Operating Expense 38.23
Net Profit 9.75
Net Profit Margin (%) 19.86
Earnings Per Share (EPS) 9.75
EBITDA 15.75
Effective Tax Rate (%) 24.71
Particulars MAR 2020 (Values in Cr)
Revenue 58.43
Operating Expense 49.86
Net Profit 9.62
Net Profit Margin (%) 16.46
Earnings Per Share (EPS) 9.62
EBITDA 15.12
Effective Tax Rate (%) 24.48
Particulars MAR 2024 (Values in Cr)
Book Value / Share 95.07
ROE % 23.02
ROCE % 24.40
Total Debt to Total Equity 0.30
EBITDA Margin 35.65
Particulars MAR 2020 (Values in Cr)
Book Value / Share 47.04
ROE % 27.55
ROCE % 34.65
Total Debt to Total Equity 0.07
EBITDA Margin 25.65
Particulars MAR 2019 (Values in Cr)
Book Value / Share 37.70
ROE % 18.45
ROCE % 25.54
Total Debt to Total Equity 0.02
EBITDA Margin 28.04
Particulars MAR 2024 (Values in Cr)
Book Value / Share 95.07
ROE % 26.87
ROCE % 27.76
Total Debt to Total Equity 0.33
EBITDA Margin 35.65
Particulars MAR 2023 (Values in Cr)
Book Value / Share 69.70
ROE % 20.41
ROCE % 22.40
Total Debt to Total Equity 0.22
EBITDA Margin 26.44
Particulars MAR 2022 (Values in Cr)
Book Value / Share 51.28
ROE % 24.02
ROCE % 32.38
Total Debt to Total Equity 0.00
EBITDA Margin 30.14
Particulars MAR 2021 (Values in Cr)
Book Value / Share 49.97
ROE % 21.17
ROCE % 27.42
Total Debt to Total Equity 0.03
EBITDA Margin 32.07
Particulars MAR 2020 (Values in Cr)
Book Value / Share 46.92
ROE % 25.35
ROCE % 32.48
Total Debt to Total Equity 0.04
EBITDA Margin 25.88
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 16.26
Total Assets 170.93
Total Liabilities 170.93
Total Equity 122.09
Share Outstanding 12847198
Price to Book Ratio 7.02
Return on Assets (%) 16.44
Return on Capital (%) 17.74
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 2.32
Total Assets 55.27
Total Liabilities 55.27
Total Equity 42.24
Share Outstanding 8971356
Price to Book Ratio 1.55
Return on Assets (%) 18.94
Return on Capital (%) 22.51
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 0.99
Total Assets 41.34
Total Liabilities 41.34
Total Equity 33.82
Share Outstanding 8971356
Price to Book Ratio 1.44
Return on Assets (%) 15.08
Return on Capital (%) 18.13
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 16.18
Total Assets 170.94
Total Liabilities 170.94
Total Equity 122.10
Share Outstanding 12847198
Price to Book Ratio 7.02
Return on Assets (%) 16.44
Return on Capital (%) 17.75
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 11.54
Total Assets 137.97
Total Liabilities 137.97
Total Equity 87.19
Share Outstanding 12006735
Price to Book Ratio 3.58
Return on Assets (%) 11.00
Return on Capital (%) 12.63
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 3.88
Total Assets 77.01
Total Liabilities 77.01
Total Equity 61.57
Share Outstanding 12006727
Price to Book Ratio 5.78
Return on Assets (%) 17.39
Return on Capital (%) 21.76
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 3.46
Total Assets 60.59
Total Liabilities 60.59
Total Equity 50.00
Share Outstanding 10006446
Price to Book Ratio 6.70
Return on Assets (%) 16.09
Return on Capital (%) 19.44
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 1.75
Total Assets 52.25
Total Liabilities 52.25
Total Equity 42.09
Share Outstanding 8971356
Price to Book Ratio 1.55
Return on Assets (%) 18.41
Return on Capital (%) 21.77
Particulars MAR 2024 (Values in Cr)
Net Income 38.16
Cash from Operations 30.44
Cash from Investing -33.00
Cash from Financing 9.84
Net change in Cash 7.28
Free Cash Flow 61.58
Particulars MAR 2020 (Values in Cr)
Net Income 10.47
Cash from Operations 4.58
Cash from Investing -2.90
Cash from Financing -0.47
Net change in Cash 1.20
Free Cash Flow 4.63
Particulars MAR 2019 (Values in Cr)
Net Income 6.23
Cash from Operations -5.21
Cash from Investing -0.07
Cash from Financing -0.17
Net change in Cash -5.46
Free Cash Flow -5.11
Particulars MAR 2024 (Values in Cr)
Net Income 38.16
Cash from Operations 30.44
Cash from Investing -33.09
Cash from Financing 9.85
Net change in Cash 7.20
Free Cash Flow 61.58
Particulars MAR 2023 (Values in Cr)
Net Income 20.23
Cash from Operations 17.09
Cash from Investing -51.08
Cash from Financing 38.65
Net change in Cash 4.67
Free Cash Flow 66.23
Particulars MAR 2022 (Values in Cr)
Net Income 18.00
Cash from Operations 13.41
Cash from Investing -11.91
Cash from Financing -1.08
Net change in Cash 0.41
Free Cash Flow 28.74
Particulars MAR 2021 (Values in Cr)
Net Income 12.94
Cash from Operations 3.31
Cash from Investing -0.94
Cash from Financing -0.65
Net change in Cash 1.71
Free Cash Flow 3.32
Particulars MAR 2020 (Values in Cr)
Net Income 12.74
Cash from Operations 3.87
Cash from Investing -2.90
Cash from Financing -0.20
Net change in Cash 0.75
Free Cash Flow 3.92
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 65.90 37.87 3.59 505.01 37.54 / 77.70
BLISS GVS PHARMA LTD 155.50 19.46 1.62 1637.91 92.25 / 172.40
CIPLA LTD 1455.65 25.47 4.14 117560.12 1192.85 / 1702.00
FERMENTA BIOTECH LIMITED 414.95 144.08 4.20 1221.24 145.00 / 440.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 65.90 57.30 11.20 505.01 37.54 / 77.70
AMRUTAJAN HEALTH LTD 753.60 45.84 7.31 2178.71 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 6634.15 128.84 24.41 16585.38 4050.15 / 8139.85
BLISS GVS PHARMA LTD 155.50 20.27 1.59 1637.91 92.25 / 172.40

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 723.20
  • 26 Days 731.20
  • 10 Days 717.80
  • 50 Days 752.80
  • 12 Days 713.20
  • 100 Days 776.90
  • 20 Days 725.10
  • 200 Days 701.50
731.40
PIVOT
First Resistance 742.40
Second Resistance 761.00
Third Resistance 772.00
First Support 712.80
Second Support 701.80
Third Support 683.20
RSI 46.52
MACD -18.00
Commodity Channel Index (CCI) 64.41
ADX 18.15
Williams % R -27.16

Over 1 Month

down

-4.64

Over 3 Months

down

-18.38

Over 6 Months

down

-14.80

Over 1 Year

down

21.19

Over 3 Years

down

29.92

Over 5 Years

down

64.90

Shree Ganesh Remedies Limited Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

Shree Ganesh Remedies Limited Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
29.49
Promoter Holdings
70.49
FII
0.0
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Chandulal Manubhai Kothia Shareholding of Promoter and Promoter Group 6259016.0 48.72
Hanshaben Chandubhai Kothia Shareholding of Promoter and Promoter Group 1467754.0 11.42
Pooja Gunjan Kothia Shareholding of Promoter and Promoter Group 615000.0 4.79
Gunjan Chandulal Kothia Shareholding of Promoter and Promoter Group 411583.0 3.2
Manubhai Jivabhai Kothiya Shareholding of Promoter and Promoter Group 236510.0 1.84
Gunjan Jayantibhai Dhorajiya Public Shareholding 219470.0 1.71
Babubhai K Kotadiya Public Shareholding 213409.0 1.66
V Naga Raja Naidu Public Shareholding 158250.0 1.23
Parth Chandulal Kothia Shareholding of Promoter and Promoter Group 56404.0 0.44
Kothia Ashokkumar Manubhai (huf) Shareholding of Promoter and Promoter Group 10568.0 0.08
Vilasben Ashokkumar Kothia Shareholding of Promoter and Promoter Group 0.0 0.0
Ashokkumar Manubhai Kothia Shareholding of Promoter and Promoter Group 0.0 0.0

Shree Ganesh Remedies Limited

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2023-09-07 0.5 Final 2023-09-07 Equity shares 2022-09-15 0.5 Final 2022-09-16 Equity shares 2021-09-08 1.75 Final 2021-09-11 Equity shares 2020-09-01 1.5 Final 2020-09-02 Equity shares 2019-08-22 1.25 Final 2019-08-24 Equity shares 2018-09-19 1.0 Final 2018-09-22 Equity shares
Ex-Date Ex-Bonus Ratio
2021-11-02 2021-11-01 1:5 2020-10-07 2020-10-06 3:26
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About Shree Ganesh Remedies Limited

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by Shree Ganesh Remedies Limited

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Shree Ganesh Remedies Ltd?

Answer Field

The share price of Shree Ganesh Remedies Ltd for NSE is ₹ 0.00 and for BSE is ₹ 744.15.

What is the Market Cap of Shree Ganesh Remedies Ltd?

Answer Field

The market cap of Shree Ganesh Remedies Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 9,55.20 Cr. as of now.

What is the 52 Week High and Low of Shree Ganesh Remedies Ltd?

Answer Field

The 52 Week High and Low of Shree Ganesh Remedies Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 950.05 and ₹ 557.95.

How to Buy Shree Ganesh Remedies Ltd share?

Answer Field

You can trade in Shree Ganesh Remedies Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Shree Ganesh Remedies Ltd?

Answer Field

The 1 year returns on the stock has been 21.19%.

What is the Current Share Price of Shree Ganesh Remedies Ltd?

Answer Field

Shree Ganesh Remedies Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 744.15 as on Dec 11 2024 03:30 PM.

What is the Market Cap of Shree Ganesh Remedies Ltd Share?

Answer Field

The market cap of Shree Ganesh Remedies Ltd for NSE ₹ 0.0 & for BSE ₹ 9,55.20 as on Dec 11 2024 03:30 PM.

What is the P/E Ratio of Shree Ganesh Remedies Ltd Share?

Answer Field

As on Dec 11 2024 03:30 PM the price-to-earnings (PE) ratio for Shree Ganesh Remedies Ltd share is 34.01.

What is the PB ratio of Shree Ganesh Remedies Ltd Share?

Answer Field

As on Dec 11 2024 03:30 PM, the price-to-book (PB) ratio for Shree Ganesh Remedies Ltd share is 103.72.

How to Buy Shree Ganesh Remedies Ltd Share?

Answer Field

You can trade in Shree Ganesh Remedies Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Shree Ganesh Remedies Ltd Share on Bajaj Broking App?

Answer Field

To buy Shree Ganesh Remedies Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Shree Ganesh Remedies Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs+ Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4700+ Cr MTF Book

icon-with-text
loader